Ensysce Biosciences, Inc. (ENSC) Q3 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ensysce Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:04.830 Good morning and welcome to the Incise Biosciences Incorporated corporate update call. 00:00:04.830 -- 00:00:07.730 As a reminder, this conference is being recorded. 00:00:07.730 -- 00:00:11.791 Your hosts today are Dr. Lynn Kirkpatrick, Chief Executive Officer, Dr. 00:00:11.791 -- 00:00:17.112 Bill Schmidt, Chief Medical Officer, and Dave Humphrey, Chief Financial Officer. 00:00:17.112 -- 00:00:20.593 Before we begin the formal presentation, I would like to remind everyone that statements 00:00:20.593 -- 00:00:24.954 made on the call and webcast may include predictions, estimates, or other information 00:00:24.954 -- 00:00:27.372 that might be considered forward-looking. 00:00:27.372 -- 00:00:30.473 While these forward-looking statements represent our current judgment on what the future 00:00:30.473 -- 00:00:34.673 holds, they are subject to risks and uncertainties that could cause actual results to 00:00:34.673 -- 00:00:36.294 differ materially. 00:00:36.294 -- 00:00:39.954 We are cautioned not to place undue reliance on these forward-looking statements, which 00:00:39.954 -- 00:00:43.455 reflect our opinions only as of the date of this presentation. 00:00:43.455 -- 00:00:46.955 Please keep in mind that we are not obligating ourselves to revise or publicly release 00:00:46.955 -- 00:00:51.056 the results of any revision to these forward-looking statements in light of new information 00:00:51.056 -- 00:00:55.437 or future events. Throughout today's discussion, we will attempt to present some important 00:00:55.437 -- 00:00:59.397 factors relating to our business that may affect our predictions. 00:00:59.397 -- 00:01:03.819 You should also review our most recent Forms 10-Q and 10-K for more complete discussion 00:01:03.819 -- 00:01...